{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:50:44Z","timestamp":1768783844972,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.canrad.2025.104759","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T02:10:07Z","timestamp":1762567807000},"page":"104759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Radiotherapy for cancers of the oesophagus, gastroesophageal junction, and stomach"],"prefix":"10.1016","volume":"29","author":[{"given":"Corentin","family":"Pasquier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Cr\u00e9hange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Vendrely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Bessi\u00e8res","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Qu\u00e9ro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anouchka","family":"Modesto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.canrad.2025.104759_bib0230","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.dld.2023.07.015","article-title":"Esophageal cancer - French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, GERCOR, Unicancer, SFCD, SFED, SFRO, ACHBT, SFP, Renape, SNFCP, Afef, SFR)","volume":"55","author":"Veziant","year":"2023","journal-title":"Dig Liver Dis"},{"issue":"7","key":"10.1016\/j.canrad.2025.104759_bib0235","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S1470-2045(11)70142-5","article-title":"Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis","volume":"12","author":"Sjoquist","year":"2011","journal-title":"Lancet Oncol"},{"issue":"22","key":"10.1016\/j.canrad.2025.104759_bib0240","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"Van Hagen","year":"2012","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.canrad.2025.104759_bib0245","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.athoracsur.2019.04.008","article-title":"Neoadjuvant therapy vs upfront surgery for clinical T2N0 esophageal cancer: a systematic review","volume":"108","author":"Kidane","year":"2019","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"10.1016\/j.canrad.2025.104759_bib0250","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(25)00027-0","article-title":"Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial","volume":"26","author":"Van Der Wilk","year":"2025","journal-title":"Lancet Oncol"},{"issue":"13","key":"10.1016\/j.canrad.2025.104759_bib0255","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa2032125","article-title":"Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer","volume":"384","author":"Kelly","year":"2021","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.canrad.2025.104759_bib0260","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM199206113262403","article-title":"Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus","volume":"326","author":"Herskovic","year":"1992","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.canrad.2025.104759_bib0265","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1470-2045(14)70028-2","article-title":"Definitive chemoradiotherapy with folfox versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5\/ACCORD17): final results of a randomised, phase 2\/3 trial","volume":"15","author":"Conroy","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2025.104759_bib0270","doi-asserted-by":"crossref","first-page":"104134","DOI":"10.1016\/j.esmoop.2025.104134","article-title":"ESMO clinical practice guideline interim update on the treatment of locally advanced oesophageal and oesophagogastric junction adenocarcinoma and metastatic squamous-cell carcinoma","volume":"10","author":"Obermannov\u00e1","year":"2025","journal-title":"ESMO Open"},{"key":"10.1016\/j.canrad.2025.104759_bib0275","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijsu.2020.06.046","article-title":"A meta-analysis on surgery with or without postoperative radiotherapy to treat squamous cell esophageal carcinoma","volume":"80","author":"Lin","year":"2020","journal-title":"Int J Surg"},{"issue":"2","key":"10.1016\/j.canrad.2025.104759_bib0280","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1053\/j.gastro.2019.04.017","article-title":"Efficacy of endoscopic resection and selective chemoradiotherapy for stage I esophageal squamous cell carcinoma","volume":"157","author":"Minashi","year":"2019","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.canrad.2025.104759_bib0285","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.brachy.2018.01.010","article-title":"Endoluminal high-dose-rate brachytherapy for locally recurrent or persistent esophageal cancer","volume":"17","author":"Taggar","year":"2018","journal-title":"Brachytherapy"},{"issue":"8","key":"10.1016\/j.canrad.2025.104759_bib0290","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jtho.2020.04.032","article-title":"Short-course external beam radiotherapy versus brachytherapy for palliation of dysphagia in esophageal cancer: a matched comparison of two prospective trials","volume":"15","author":"Jeene","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2025.104759_bib0295","first-page":"24","article-title":"Effectiveness of several external beam radiotherapy schedules for palliation of esophageal cancer","volume":"17","author":"Walterbos","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"issue":"9444","key":"10.1016\/j.canrad.2025.104759_bib0300","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S0140-6736(04)17272-3","article-title":"Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial","volume":"364","author":"Homs","year":"2004","journal-title":"Lancet"},{"issue":"10184","key":"10.1016\/j.canrad.2025.104759_bib0305","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"Al-Batran","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.canrad.2025.104759_bib0310","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa2409408","article-title":"Perioperative chemotherapy or preoperative chemoradiotherapy in esophageal cancer","volume":"392","author":"Hoeppner","year":"2025","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.canrad.2025.104759_bib0315","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa010187","article-title":"Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction","volume":"345","author":"Macdonald","year":"2001","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.canrad.2025.104759_bib0320","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJMoa2405195","article-title":"Preoperative chemoradiotherapy for resectable gastric cancer","volume":"391","author":"Leong","year":"2024","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.canrad.2025.104759_bib0325","doi-asserted-by":"crossref","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","article-title":"Gastric cancer, version 2.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"20","author":"Ajani","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"10.1016\/j.canrad.2025.104759_bib0330","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S1470-2045(18)30132-3","article-title":"Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial","volume":"19","author":"Cats","year":"2018","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104759_bib0335","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.annonc.2020.11.017","article-title":"A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial","volume":"32","author":"Park","year":"2021","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.canrad.2025.104759_bib0340","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","article-title":"Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Lordick","year":"2022","journal-title":"Ann Oncol"},{"issue":"19","key":"10.1016\/j.canrad.2025.104759_bib0345","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1200\/JCO.2011.36.7136","article-title":"Updated analysis of SWOG-directed intergroup Study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection","volume":"30","author":"Smalley","year":"2012","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.canrad.2025.104759_bib0350","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1245\/s10434-017-6048-3","article-title":"Adjuvant chemoradiotherapy for non-pretreated gastric cancer","volume":"24","author":"Ho","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.canrad.2025.104759_bib0355","doi-asserted-by":"crossref","first-page":"103693","DOI":"10.1016\/j.clon.2024.103693","article-title":"Reconsidering the role of radiotherapy for inoperable gastric cancer: a systematic review of gastric radiotherapy given with definitive and palliative intent","volume":"37","author":"Case","year":"2025","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.canrad.2025.104759_bib0360","doi-asserted-by":"crossref","first-page":"100266","DOI":"10.1016\/j.tipsro.2024.100266","article-title":"Hemostatic palliative radiotherapy for gastric cancer: A literature review","volume":"31","author":"Tanaka","year":"2024","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104759_bib0365","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.radonc.2004.10.001","article-title":"Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?","volume":"73","author":"Vrieze","year":"2004","journal-title":"Radiother Oncol"},{"issue":"25","key":"10.1016\/j.canrad.2025.104759_bib0370","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1200\/JCO.20.03697","article-title":"Randomized Study on dose escalation in definitive chemoradiation for patients with locally advanced esophageal cancer (ARTDECO Study)","volume":"39","author":"Hulshof","year":"2021","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.canrad.2025.104759_bib0375","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1470-2045(21)00718-X","article-title":"Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology\/RTOG 1010): a multicentre, randomised, phase 3 trial","volume":"23","author":"Safran","year":"2022","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.canrad.2025.104759_bib0380","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jamaoncol.2017.1598","article-title":"Effect of the addition of cetuximab to paclitaxel, cisplatin, and radiation therapy for patients with esophageal cancer: the NRG Oncology RTOG 0436 phase 3 randomized clinical trial","volume":"3","author":"Suntharalingam","year":"2017","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104759_bib0385","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.ijrobp.2021.07.045","article-title":"Exclusive chemoradiotherapy with or without radiation dose escalation in esophageal cancer: multicenter phase 2\/3 randomized trial CONCORDE (PRODIGE-26)","volume":"111","author":"Cr\u00e9hange","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.canrad.2025.104759_bib0390","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1158\/1078-0432.CCR-21-3843","article-title":"A phase III multicenter randomized clinical trial of 60Gy versus 50Gy radiation dose in concurrent chemoradiotherapy for inoperable esophageal squamous cell carcinoma","volume":"28","author":"Xu","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.canrad.2025.104759_bib0395","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.ijrobp.2022.11.006","article-title":"High-dose versus standard-dose intensity-modulated radiotherapy with concurrent paclitaxel plus carboplatin for patients with thoracic esophageal squamous cell carcinoma: a randomized, multicenter, open-label, phase 3 superiority trial","volume":"115","author":"You","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.canrad.2025.104759_bib0400","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/cac2.12601","article-title":"Concurrent chemoradiotherapyof different radiation doses and different irradiation fields for locally advanced thoracic esophageal squamous cell carcinoma: A randomized, multicenter, phase III clinical trial","volume":"44","author":"Zhang","year":"2024","journal-title":"Cancer Commun(Lond)"},{"key":"10.1016\/j.canrad.2025.104759_bib0405","doi-asserted-by":"crossref","first-page":"109463","DOI":"10.1016\/j.radonc.2023.109463","article-title":"High versus standard radiation dose of definitive concurrent chemoradiotherapy for esophageal cancer: A systematic review and meta-analysis of randomized clinical trials","volume":"180","author":"Wang","year":"2023","journal-title":"Radiother Oncol"},{"issue":"15","key":"10.1016\/j.canrad.2025.104759_bib0410","doi-asserted-by":"crossref","first-page":"25797","DOI":"10.18632\/oncotarget.15554","article-title":"Palliative radiotherapy for gastric cancer: a systematic review and meta-analysis","volume":"8","author":"Tey","year":"2017","journal-title":"Oncotarget"},{"issue":"1111","key":"10.1016\/j.canrad.2025.104759_bib0415","doi-asserted-by":"crossref","first-page":"20190958","DOI":"10.1259\/bjr.20190958","article-title":"Hemostatic radiotherapy for inoperable gastric cancer: a pilot study","volume":"93","author":"Tanaka","year":"2020","journal-title":"Br J Radiol"},{"issue":"5","key":"10.1016\/j.canrad.2025.104759_bib0420","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/jrr\/rry055","article-title":"Comparison of elective nodal irradiation and involved-field irradiation in esophageal squamous cell carcinoma: a meta-analysis","volume":"59","author":"Cheng","year":"2018","journal-title":"J Radiat Res"},{"issue":"1","key":"10.1016\/j.canrad.2025.104759_bib0425","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jtho.2016.10.016","article-title":"Cancer of the esophagus and esophagogastric junction: an eighth edition staging primer","volume":"12","author":"Rice","year":"2017","journal-title":"J Thorac Oncol"},{"issue":"2","key":"10.1016\/j.canrad.2025.104759_bib0430","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10120-011-0041-5","article-title":"Japanese classification of gastric carcinoma: 3rd English edition","volume":"14","year":"2011","journal-title":"Gastric Cancer"},{"issue":"2","key":"10.1016\/j.canrad.2025.104759_bib0435","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.radonc.2009.03.018","article-title":"EORTC-ROG expert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach","volume":"92","author":"Matzinger","year":"2009","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2025.104759_bib0440","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ijrobp.2012.02.015","article-title":"Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer","volume":"84","author":"Lin","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.canrad.2025.104759_bib0445","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/cncr.29857","article-title":"Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer","volume":"122","author":"Lin","year":"2016","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.canrad.2025.104759_bib0450","doi-asserted-by":"crossref","first-page":"e2328136","DOI":"10.1001\/jamanetworkopen.2023.28136","article-title":"Efficacy and safety in proton therapy and photon therapy for patients with esophageal cancer: a meta-analysis","volume":"6","author":"Zhou","year":"2023","journal-title":"JAMA Netw Open"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321825001751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321825001751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T12:18:20Z","timestamp":1768738700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321825001751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":45,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1278321825001751"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104759","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy for cancers of the oesophagus, gastroesophageal junction, and stomach","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104759","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104759"}}